Biomedical Engineering Reference
In-Depth Information
REFERENCES
1. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al.
Optimal assessment and management of chronic obstructive pulmonary
disease (COPD). European Respiratory Society consensus statement. Eur
Respir J 1995; 8:1398-1420.
2. Celli B, Snider GL, Heffner J, Tiep B, Ziment I, Make B, et al. Standards for
the diagnosis and care of patients with chronic obstructive pulmonary disease.
Official statement of the American Thoracic Society. Am J Respir Crit Care
Med 1995; 152:S77-S120.
3. Barbera JA, Peces-Barba G, Agust´ AG, Izquierdo JL, Monso E,
Montemayor T, et al. Gu´a cl´nica para el diagn´ stico y el tratamiento de
la enfermedad pulmonar obstructiva cr´nica. Arch Bronconeumol 2001;
37(6):297-316.
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy
for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease. NHLBI
=
WHO Global Initiative for Chronic Obstruc-
tive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care
Med 2001; 163(5):1256-1276.
5. Agust´ AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic
effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21(2):
347-360.
6. Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease. Inflam-
mation of small airways and lung parenchyma. Am J Respir Crit Care Med
1999; 160(5 Pt 2):S21-S25.
7. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress
in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154(4):
1055-1060.
8. Pratico D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic
obstructive pulmonary disease is associated with an increase in urinary levels
of isoprostane F2a-H, an index of oxidant stress. Am J Respir Crit Care Med
1998; 158:1709-1714.
9. Morrow JD, Frei B, Longmire WA, Gaziano M, Lynch SM, Shyr Y, et al.
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in
smokers. N Engl J Med 1995; 332(18):1198-1203.
10. Burnett D, Hill SL, Chamba A, Stockley RA. Neutrophils from subjects with
chronic obstructive lung disease show enhanced chemotaxis and extracellular
proteolysis. Lancet 1987; 2:1043-1046.
11. Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, et al.
Enhanced neutrophil response in chronic obstructive pulmonary disease.
Thorax 2001; 56(6):432-437.
12. Noguera A, Busquets X, Sauleda J, Villaverde JM, MacNee W, Agust´ AGN.
Expression of adhesion molecules and G proteins in circulating neutrophils in
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;
158:1664-1668.
13. Noguera A, Sala E, Pons AR, Iglesias J, MacNee W, Agust
´
AGN. Expression
of adhesion molecules during apoptosis of circulating neutrophils in COPD.
Chest. 2004; 125:1837-1842.
